Bed, Bath and Bankruptcy
Bed, Bath and Bankruptcy
And other unique ideas for the week
Good morning everyone.
Bed, Bath and Beyond (BBBY) filed for bankruptcy over the weekend in typical shitco fashion. The equity will be interesting to keep an eye on given the meme stock status and potential for any restructuring. I plan to read the bankruptcy documents as they get filed for curiosity purposes and to get better informed on what happens during a restructuring. If you missed it, I have recently invested in a bankrupt company that looks pretty interesting.
This week will be pretty busy with earnings for Q1 starting to come out. Keep up with the news flow in the Telegram channel (for pro subscribers). Long-from updates will hit your inbox as they come out.
Insider buying activity has slowed down given the blackout periods but should pick up as Q1 reports are released and executives are no longer in blackout.
Lastly, I wrote up a tiny little company last week. Check it out and let me know your thoughts. It might be one of the most interesting situations I have seen in a long-time.
Now before we get into the insider buys of the week, first a word from today’s sponsor…
Put Quantum Power In Your Portfolio with Ingenii
Say goodbye to the limitations of classical computing and hello to a world of endless possibilities. Quantum computing is the future, and Ingenii's flexible and turnkey algorithm library is the key to unlocking its potential.
Designed for data scientists with no quantum expertise, Ingenii's product enables faster and more efficient calculations and solves problems that are not possible on classical hardware. The company’s data engineering automation, turnkey workspaces, and marketplace of algorithms make accessing quantum computing easy and affordable.
And right now, Ingenii is raising funds on Republic to scale quantum technology to the world.
Already earning $60k ARR from 3 data engineering subscribers with a 100% subscription renewal rate, the subscription-based model boasts a 90% profit margin thanks to reusable code. Industry leaders across the top ten healthcare and pharmaceutical companies have already subscribed to their open-source quantum library along with over 100 others.
With 74% of enterprises planning to adopt quantum computing within the next year and 90% already using open-source software, the demand for quantum computing solutions is skyrocketing. Invest with us on our mission to revolutionize the data landscape and unlock the true potential of quantum computing.
Are you ready to take the leap into the future of computing?
Invest Ingenii today and become the future. Opportunity ends soon!
Insider Buys And Other Unique Ideas
The Singing Machine (MICS) had a small insider buy this past week. The buys have been coming from a gentleman named Milton “Todd” Ault III. I have seen Ault’s filings pop up before on other microcap stocks. Ault is the founder of Ault Alliance, BitNile (NILE), DPW Holdings and a number of other microcap companies that have had a history of shareholder losses and investments in strange technologies. Ault has a shadier history, but despite the past history, he has become quite aggressive and now owns over 57% of the total company. The market cap of The Singing Machine is only $4.6 million and is trading at a multiyear low. There is $.27 million of cash on the balance sheet, $7 million of accounts receivable, $10 million of inventories and only $1.7 million of debt and $2 million of payables. The business model is selling karaoke machines and toys to kids. Revenues have plummeted over the past year and losses are starting to mount. If the company liquidated now you would make a good return selling off the inventory, collecting the AR and returning capital. Ault might see this as his play and the reason for the big increase in his ownership. Ault will talk to you if you reach out to him. This name looks pretty unique and actionable.
The CFO of Joann Inc. (JOAN) purchased a decent amount of shares in the open market. Joann is a beaten down retailer that trades with a market cap of only $73 million. The short interest is 24% so there might be some torque in the share price should any positive news flow. In the most recent quarter the company executed on a new credit agreement and talked about reducing annual costs by $20 million. There is $200 million of cash on the balance sheet offset by $976 million of debt — high cost of over 10%. Outside of the trade name impairment and adding back D&A, the company did generate operating income. The company is highly levered and trends are not heading in the right direction. But the insider buy at this depressed level is nice to see. If the company survives this is a multi bagger. If they can’t turn around comps, take out costs and generate cash it is a zero.
There was a $110k insider buy at a small microcap called Cosmos Health Inc. (COSM). The company is a $33 million market cap Pharma company and has $20 million of cash and $13.5 million of debt on the balance sheet. I am not familiar with the story but there has been two bullish and well written articles on Seeking Alpha (here and here) that go over the thesis. This might be a good one to spend an hour or so on to see if there is any juice in the thesis. The recent share repurchase program and de-levered balance sheet seem like positive events for equity holders.
The biggest bank insider transaction of the past week occurred with ServisFirst Bancshares (SFBS), with the CEO purchasing $150k in the open market. ServisFirst Bancshares is a $2.7 billion market cap bank that is down 40% over the past years. The dividend yield is 2.2% and is trading with a P/E ratio of 11x and P/B of 2.0x. The bank is based in Alabama and has incredible profitability metrics.
Bed Bath & Beyond (BBY) filed for bankruptcy over the weekend. 480 stores (360 Bed Bath & Beyond and 120 buybuy BABY) will remain open as the rest of the assets are auctioned off during the restructuring process. I’m not sure what happens post-restructuring, but if the equity ever trades again it might be a good one to keep an eye on.
A pro member recently highlighted his recent buy of ADMQ in the comment section of my most recent writeup. ADMQ was first bought up in a previous edition of “insider buys of the week”. The stock trades at only $0.04 and remains unknown, illiquid and interesting. The member stated that their new production facility will 5x their business and they currently remain profitable — a rare feat for a company with a $0.04 stock price. The CEO owns 40% of the company.
Disclosure: I don’t own any stock mentioned in today’s newsletter.
Disclaimer: The publisher does not guarantee the accuracy or completeness of the information provided in this page. All statements and expressions herein are the sole opinion of the author or paid advertiser.
Alpha Letter is a publisher of financial information, not an investment advisor. We do not provide personalized or individualized investment advice or information that is tailored to the needs of any particular recipient.
THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, AND DOES NOT PURPORT TO BE AND DOES NOT EXPRESS ANY OPINION AS TO THE PRICE AT WHICH THE SECURITIES OF ANY COMPANY MAY TRADE AT ANY TIME. THE INFORMATION AND OPINIONS PROVIDED HEREIN SHOULD NOT BE TAKEN AS SPECIFIC ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. INVESTORS SHOULD MAKE THEIR OWN INVESTIGATION AND DECISIONS REGARDING THE PROSPECTS OF ANY COMPANY DISCUSSED HEREIN BASED ON SUCH INVESTORS’ OWN REVIEW OF PUBLICLY AVAILABLE INFORMATION AND SHOULD NOT RELY ON THE INFORMATION CONTAINED HEREIN.
No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned.
Any projections, market outlooks or estimates herein are forward looking statements and are inherently unreliable. They are based upon certain assumptions and should not be construed to be indicative of the actual events that will occur. Other events that were not taken into account may occur and may significantly affect the returns or performance of the securities discussed herein. The information provided herein is based on matters as they exist as of the date of preparation and not as of any future date, and the publisher undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional material.
The publisher, its affiliates, and clients of the a publisher or its affiliates may currently have long or short positions in the securities of the companies mentioned herein, or may have such a position in the future (and therefore may profit from fluctuations in the trading price of the securities). To the extent such persons do have such positions, there is no guarantee that such persons will maintain such positions.
Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein.
By using the Site or any affiliated social media account, you are indicating your consent and agreement to this disclaimer and our terms of use. Unauthorized reproduction of this newsletter or its contents by photocopy, facsimile or any other means is illegal and punishable by law.
For Full Terms of Use Click HERE. For the Privacy Policy Click HERE.
alphaletter.co (“Alpha”) is a website owned and operated by Substack. Alpha is paid fees by the companies that make investment offerings on this website. Be aware that payment of these fees may put Alpha in a conflict of interest with the investor. By accessing this website or any page thereof, you agree to be bound by the Terms of Use and Privacy Policy, in effect at the time you access this website or any page thereof. The Terms of Use and Privacy Policy may be amended from time to time. Nothing on this website shall constitute an offer to sell, or a solicitation of an offer to buy or subscribe for, any securities to any person in any jurisdiction where such an offer or solicitation is against the law or to anyone to whom it is unlawful to make such offer or solicitation. Alpha is not an underwriter, broker-dealer, Title III crowdfunding portal or a valuation service and does not engage in any activities requiring any such registration. Alpha does not provide advice on investments or structure transactions. Offerings made under Regulation A under the U.S. Securities Act of 1933, as amended (the "Securities Act") are available to U.S. investors who are “accredited investors” as defined by Rule 501 of Regulation D under the Securities Act well as non-accredited investors, who are subject to certain investment limitations as set forth in Regulation A under the Securities Act. In order to invest in Regulation A offerings, investors may be asked to fill out a certification and provide necessary documentation as proof of your income and/or net worth to verify that you are qualified to invest in offerings posted on this website. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Alpha does not verify the adequacy, accuracy or completeness of any information. Neither Alpha nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, valuations of securities or completeness of any information on this site or the use of information on this site. Neither Alpha nor any of its directors, officers, employees, representatives, affiliates or agents shall have any liability whatsoever arising from any error or incompleteness of fact, or lack of care in the preparation of, any of the materials posted on this website. Investing in securities, especially those issued by start-up companies, involves substantial risk. investors should be able to bear the loss of their entire investment and should make their own determination of whether or not to make any investment based on their own independent evaluation and analysis